CACNa1H ELISA kit
- Known as:
- CACNa1H Enzyme-linked immunosorbent assay test reagent
- Catalog number:
- DL-CACNa1H-Mu
- Product Quantity:
- 96T
- Category:
- Elisa Kits
- Supplier:
- WDSTD
- Gene target:
- CACNa1H ELISA kit
Related genes to: CACNa1H ELISA kit
- Gene:
- CACNA1H NIH gene
- Name:
- calcium voltage-gated channel subunit alpha1 H
- Previous symbol:
- -
- Synonyms:
- Cav3.2
- Chromosome:
- 16p13.3
- Locus Type:
- gene with protein product
- Date approved:
- 1999-01-08
- Date modifiied:
- 2016-02-04
Related products to: CACNa1H ELISA kit
Human ELC ELISA KIT 96 TEST
OxiSelect In Vitro ROS/RNS Assay Kit (Green Fluorescence), Trial Size
OxiSelect Methylglyoxal (MG) Competitive ELISA Kit
OxiSelect Methylglyoxal (MG) Competitive ELISA Kit
OxiSelect TBARS Assay Kit (MDA Quantitation), Trial Size
OxiSelect Total Antioxidant Capacity (TAC) Assay Kit, Trial Size
OxiSelect™ In Vitro ROS RNS Assay Kit (Green Fluorescence), Trial Size(1-3)-beta-D-glucan Sandwich ELISA, Double Antibody(1-Kit )11,12-EET DHET Immunoassay Kit(1-Kit )11,12-EET_DHET Immunoassay Kit(1-Kit) 11,12-DHET Immunoassay Kit(1-Kit) 14,15-DHET Human Urine ELISA Kit(1-Kit) 14,15-DHET Hypertension ELISA Kit(1-Kit) 14,15-DHET sEH activity ELISA Kit(1-Kit) 14,15-EET DHET Hypertension ELISA Kit Related articles to: CACNa1H ELISA kit
- Sex differences in major depressive disorder (MDD) are well documented, but it remains unclear whether sex-related variation in peripheral endocannabinoid system (ECS)-related biomarkers is detectable in MDD. - Source: PubMed
Publication date: 2026/08/25
Sorkhou MaryamKim Helena KFarzan FaranakFoster Jane AFrey Benicio NHusain Muhammad IKennedy Sidney HLam Raymond WMilev RoumenMulsant Benoit HMüller Daniel JQuilty Lena CSoares Claudio NTaylor Valerie HTurecki GustavoKloiber Stefan - The germline genetic basis of bilateral primary aldosteronism (PA) remains poorly understood, particularly in apparently sporadic disease. We investigated rare germline variants in canonical and candidate genes in patients with bilateral PA associated with resistant hypertension and/or hypertension diagnosed before 40 years of age. - Source: PubMed
Publication date: 2026/07/27
Santana Lucas SAlves-Fernandes Débora KLima Sobrinho Jose Antonio BFreitas-Castro FelipeRossetti Lucas BOkubo JessicaFagundes Gustavo F CKawahara Eduardo ZMendes Thiago SBortolotto Luiz APio-Abreu AndreaSilva Giovanio VDrager Luciano FLatronico Ana ClaudiaAlmeida Madson Q - Three-dimensional genome organization stabilizes cell-type-specific gene expression, yet the tissue-restricted factors that maintain chromatin insulation remain poorly understood. Here, we identify the muscle-specific ribosomal protein Rpl3l as an unexpected nuclear regulator of genome architecture in atrial cardiomyocytes. Rpl3l is enriched in the nucleus and nucleolus, where it binds its own genomic locus and stabilizes a CTCF-anchored chromatin boundary that represses the T-type calcium channel gene . Loss of weakens local chromatin insulation, increases long-range contacts across the - locus, derepresses , and increases susceptibility to atrial fibrillation (AF), which is suppressed by pharmacological inhibition of T-type calcium channels. Furthermore, AF-associated RPL3L variants exhibit impaired nucleolar localization, reduced rRNA binding, and defective repression of in human iPSC-derived atrial cardiomyocytes. Together, these findings reveal a ribosomal protein-chromatin axis linking genome insulation to ion-channel dosage control and cardiac rhythm stability, expanding the repertoire of cell-type-specific genome architecture regulators. - Source: PubMed
Publication date: 2026/06/26
Nakamura MakotoChen XiaoxinYao ShunChan Lynette XinHongmei RuanBoulinguiez AlexisLally NavWu HaoKodani KaraHirose KentaroPirruccello JamesMalerba AlbertoCheng YifanVedantham VasanthTan LongzhiOlgin Jeffrey ELang DiHuang Guo N - Depression has been increasingly associated with cancer progression and patient outcomes, yet its molecular and immunological correlates within tumors remain incompletely understood. This study aimed to investigate depression-associated gene signature across cancers and evaluate their relationship with tumor biology, immune microenvironment, and clinical outcomes, with a focus on breast cancer. - Source: PubMed
Publication date: 2026/06/12
Chen GuanlingYin BaoliangKhan MuhammadYang YipengSun QianZhang TingfengHu HongLin Jie - Disruption of cation homeostasis is increasingly recognized as a driver of breast cancer (BC) progression, yet a clinically actionable gene signature that quantifies this disturbance has been lacking. This study aims to systematically explore the value of cation homeostasis-related genes in the prognosis assessment of BC through bioinformatics analysis, construct and validate a prognostic model based on these genes, and integrate immune mechanism and drug sensitivity analyses to provide novel biomarkers and potential therapeutic targets for precise prognosis evaluation and individualized treatment of BC. - Source: PubMed
Publication date: 2026/04/29
Xu MingxingYe ZhihaoHong WeiminZhu LiquanHe ChaoqiYang ZhuotaoHu JunsiQian DaMeng XuliRen Zhuozhuo